Pfannschmidt J, Klode J, Muley T, Hoffmann H, Dienemann H
Department of Thoracic Surgery, Thoraxklinik Heidelberg, University of Heidelberg, Germany.
Thorac Cardiovasc Surg. 2006 Mar;54(2):120-3. doi: 10.1055/s-2005-872855.
The use of pulmonary resection for metastatic osteosarcoma as an interdisciplinary treatment concept is being established. The purpose of this study was to determine the clinical course, outcome and prognostic factors in a subset of patients having undergone aggressive polychemotherapy in the most recent period and metastasectomy.
Between 1997 and 2001, 21 patients (8 men, 13 women) with pulmonary metastases from osteosarcoma of the limb underwent surgical resection. Exclusion of primary tumor recurrence and other extrapulmonary metastases was mandatory for inclusion in the study. Complete resection was achieved in 18 patients. The median follow-up was 60.6 months.
Cumulative 5-year survival after complete resection was 34.2%. Of the prognostic factors analyzed, age, sex, repeated thoracotomy, and histologic grading did not influence survival. Complete resection was found to be a significant prognostic factor for survival following metastasectomy (p = 0.04). There was a tendency towards longer survival in patients with less than 7 pulmonary metastases compared to patients with more than 7 metastases, but the difference was not statistically significant (p = 0.07).
With pulmonary metastases of osteosarcoma, every attempt should be made to completely resect all clinically detected metastases. Repeat thoracotomy in recurrent disease is compatible with long-term survival.
将肺切除术用于转移性骨肉瘤作为一种多学科治疗理念正在逐步确立。本研究的目的是确定近期接受强化多药化疗及转移灶切除术的部分患者的临床病程、结局和预后因素。
1997年至2001年间,21例(8例男性,13例女性)肢体骨肉瘤肺转移患者接受了手术切除。纳入研究必须排除原发性肿瘤复发和其他肺外转移。18例患者实现了完全切除。中位随访时间为60.6个月。
完全切除后的5年累积生存率为34.2%。在分析的预后因素中,年龄、性别、再次开胸手术和组织学分级均不影响生存率。发现完全切除是转移灶切除术后生存的一个重要预后因素(p = 0.04)。与有7个以上转移灶的患者相比,有不到7个肺转移灶的患者有生存时间更长的趋势,但差异无统计学意义(p = 0.07)。
对于骨肉瘤肺转移,应尽一切努力完全切除所有临床检测到的转移灶。复发性疾病再次开胸手术与长期生存是相容的。